The Palliative Effect of TENS-WAA on 'Capsaicin/Heat' Induced Acute Lower Back Pain: a Self-controlled Clinical Study
Launched by XIAONAN HUANG · Apr 17, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new pain relief method for acute lower back pain using a device called Transcutaneous Electrical Nerve Stimulation based on Wrist-Ankle Acupuncture theory (TENS-WAA). The study aims to determine if this device can effectively reduce pain caused by a model that simulates acute back pain using capsaicin, a substance derived from chili peppers that activates pain receptors in the body. The trial will measure how well TENS-WAA works by looking at changes in blood flow in the brain areas that process pain and by asking participants to rate their pain levels.
To participate in this trial, individuals must be healthy adult males aged 18 to 44, who have no recent pain and are not on any medications that could affect their pain perception. Importantly, those with serious health issues, a history of spinal surgery, or certain allergies will not be eligible. Participants can expect to wear the TENS-WAA device on their wrist or ankle during the study, which is designed to be safe and easy to use. This trial is still in the planning stages and is not yet recruiting participants.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy adult males between the ages of 18-44 years;
- • The dominant hand is the right hand;
- • No persistent pain in the last month;
- • No acute pain in the last week;
- • Good health with no medical condition for which he/she is receiving treatment;
- • Subjects agreed to participate in this trial and signed an informed consent form.
- Exclusion Criteria:
- • With malignant tumours and serious heart, liver and kidney diseases;
- • Those with skin breakage at the site of capsaicin application;
- • Those with a history of lumbar spine surgery, spinal fracture, rheumatic disease, cancer, pacemaker, or congenital anomalies of the spine;
- • Any other medical condition that may affect pain perception, including neurological and psychiatric disorders;
- • Taking sedative and sleep-aiding drugs within one week;
- • Those who are allergic to capsaicin;
- • Currently participating in another clinical trial concerning lower back pain or pain.
About Xiaonan Huang
Xiaonan Huang is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Xiaonan leads initiatives that prioritize rigorous methodology and ethical standards in clinical trials. By fostering collaborations with healthcare professionals and research institutions, Xiaonan aims to facilitate the development of safe and effective treatments across various medical fields. Their expertise in clinical operations and regulatory compliance ensures that trials are conducted efficiently and transparently, ultimately contributing to the enhancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported